DEXCOM INC — Director's Dealing 2016

Sep 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-09-07

Reporting Person: FOLETTA MARK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-07	Common Stock	S	1800.0	$94.625	Disposed	15643	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $94.60 to $94.68. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: Included in this number are 10,027 unvested restricted stock units, 5,450 of which were granted on May 25, 2016 and shall vest on May 25, 2017 and 4,577 of which were granted on November 17, 2014 and shall vest through November 17, 2017.